Stay updated on Anamorelin HCl in NSCLC-C: Clinical Trial
Sign up to get notified when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.

Latest updates to the Anamorelin HCl in NSCLC-C: Clinical Trial page
- Check7 days agoChange DetectedThe ROMANA 3 study page now shows a 403 error and the detailed study content has been removed, leaving only navigation and footer information.SummaryDifference15%

- Check14 days agoChange DetectedThe study locations in Israel were updated. Qiryat Krinitzi was removed and Tel Litwinsky was added.SummaryDifference0.0%

- Check21 days agoChange DetectedA new study site, Qiry Krinitzi, Israel, has been added to the locations list, and Tel Litwinsky, Israel has been removed; this updates the geographic options for enrollment and site coverage.SummaryDifference0.0%

- Check28 days agoChange DetectedThe page shows a new revision label Revision: v3.6.6, replacing Revision: v3.6.5, indicating a minor update to the document revision history.SummaryDifference0.0%

- Check49 days agoChange DetectedAn error page HTML is now shown in place of the ROMANA 3 study record content, so the page displays an 'An error occurred' message rather than the trial details. This indicates the record is currently unavailable and unable to present study information.SummaryDifference14%

- Check63 days agoChange Detected- The page revision tag updated from v3.6.3 to v3.6.4, indicating a small software/version update. - This update does not modify the study details or substantive content presented on the page.SummaryDifference0.0%

Stay in the know with updates to Anamorelin HCl in NSCLC-C: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anamorelin HCl in NSCLC-C: Clinical Trial page.